MENU
+Compare
ZLDPF
Stock ticker: OTC
AS OF
Aug 7 closing price
Price
$50.14
Change
-$0.06 (-0.12%)
Capitalization
3.65B

ZLDPF Zealand Pharma A/S Forecast, Technical & Fundamental Analysis

Zealand Pharma AS is a biotechnology company... Show more

ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ZLDPF with price predictions
Aug 08, 2025

ZLDPF's RSI Oscillator sits in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ZLDPF advanced for three days, in of 85 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ZLDPF as a result. In of 57 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ZLDPF turned negative on July 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

ZLDPF broke above its upper Bollinger Band on July 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ZLDPF entered a downward trend on July 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.742) is normal, around the industry mean (18.662). P/E Ratio (0.000) is within average values for comparable stocks, (54.033). ZLDPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (400.000) is also within normal values, averaging (286.048).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZLDPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ZLDPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
ZLDPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Sydmarken 11
Phone
+45 88773600
Employees
253
Web
https://www.zealandpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHML74.910.37
+0.50%
JHancock Multifactor Large Cap ETF
ZSEP26.170.03
+0.11%
Innovator Equity Defined Prot ETF-1YrSep
MLPB25.67N/A
N/A
UBS ETRACS Alerian MLPInfrs ETN SerB
PGRO42.13N/A
N/A
Putnam Focused Large Cap Growth ETF
NZUS33.40N/A
N/A
SPDR MSCI USA Climate Paris Aligned ETF

ZLDPF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDPF has been loosely correlated with IMRN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDPF jumps, then IMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDPF
1D Price
Change %
ZLDPF100%
N/A
IMRN - ZLDPF
52%
Loosely correlated
+5.56%
MNMD - ZLDPF
32%
Poorly correlated
-1.40%
VICP - ZLDPF
28%
Poorly correlated
N/A
GLSI - ZLDPF
26%
Poorly correlated
+4.37%
LTRN - ZLDPF
23%
Poorly correlated
N/A
More